Dover Corporation (DOV)
NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-07-07
$214.06-0.32%
Close 2026-07-07 · 1-day change
Reading DOV? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DOV free→NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-07-07
Reading DOV? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DOV free→QuarterlyIQ Insights · DOV
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $214.06. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $214 DOV trades at 22× p/e, below its 31× p/e peer median. Our $224 fair value sits above the price. It's a high-confidence read. Analysts target $229–$279. Note: our $224 fair value sits below the entire analyst range ($229–$279). Not investment advice.
$229.00 – $279.00 (median $250.00) · 9 analysts · as of 2026-06-04
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $12.99/sh owner earnings.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $250.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $197.13 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $203.00 | — | — | Hist. CAGR | high |
| graham number | 12M | $110.52 | — | — | TTM | high |
| Mgmt guidance | 12M | $281.97 | 31.3 | 9.02 | Mgmt | high |
| Peer EV/EBITDA | 12M | $229.91 | 19.2 | 12.60 | TTM | high |
| Peer P/FCF | 12M | $224.41 | 26.8 | 8.37 | TTM | high |
| Peer P/E | 12M | $307.92 | 31.3 | 9.85 | TTM | high |
| Peer P/S | 12M | $176.69 | 2.9 | 60.93 | TTM | high |
| PEG | 12M | $341.64 | 34.7 | 9.85 | TTM | high |
| residual income | 12M | $73.66 | — | — | TTM | high |
| Own P/E history | 12M | $212.67 | 21.6 | 9.85 | TTM | high |
| triangulated | 12M | $313.92 | 31.3 | 10.04 | Triangulated | high |
| Mgmt guidance | 3Y | $390.46 | 31.3 | 12.49 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $317.39 | 26.8 | 11.84 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $293.04 | 31.3 | 9.37 | Analyst | medium |
| Peer P/S | 3Y | $156.57 | 2.9 | 53.99 | guidance | medium |
| PEG | 3Y | $325.13 | 34.7 | 9.37 | Analyst | medium |
| Own P/E history | 3Y | $202.39 | 21.6 | 9.37 | Analyst | medium |
| Mgmt guidance | 5Y | $485.09 | 31.3 | 15.52 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $399.91 | 26.8 | 14.92 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $224.66 | 31.3 | 7.19 | Analyst | high |
| Peer P/S | 5Y | $120.03 | 2.9 | 41.39 | guidance | high |
| PEG | 5Y | $249.27 | 34.7 | 7.19 | Analyst | high |
| Own P/E history | 5Y | $155.16 | 21.6 | 7.19 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.